Abstract
<div>Abstract<p><b>Background:</b> The combined action of androgens and estrogens—specifically their balance—may play a role in prostate carcinogenesis, but existing evidence is sparse and inconsistent. We investigated associations between serum sex steroid hormones, including estrogen metabolites, and risk of aggressive prostate cancer.</p><p><b>Methods:</b> In a case–control study nested within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial cohort, we measured serum estrone, estradiol, and 13 estrogen metabolites, in the 2-, 4-, or 16-hydroxylation pathways, using an LC/MS-MS assay. Cases (<i>n</i> = 195) were non-Hispanic white men ages 55 to 70 years when diagnosed with aggressive prostate cancer (stage III or IV and/or Gleason ≥7). Controls (<i>n</i> = 195) were non-Hispanic white men without prostate cancer who were frequency matched to cases by age and year at blood draw, and time since baseline screen. Only men with serum testosterone and sex hormone-binding globulin measured previously were eligible. Logistic regression models were used to estimate ORs and 95% confidence intervals (95% CI).</p><p><b>Results:</b> Risk of aggressive prostate cancer was strongly inversely associated with estradiol:testosterone ratio (OR<sub>4th quartile</sub> vs. <sub>1st</sub> = 0.27; 95% CI, 0.12–0.59, <i>P</i><sub>trend</sub> = 0.003) and positively associated with 2:16α-hydroxyestrone ratio (OR<sub>4th quartile</sub> vs. <sub>1st</sub> = 2.44; 95% CI, 1.34–4.45, <i>P</i><sub>trend</sub> = 0.001). Individual estrogen metabolites were unrelated to risk.</p><p><b>Conclusions:</b> Our findings suggest that sex steroid hormones, specifically the estrogen-androgen balance, may be important in the development of aggressive prostate cancer.</p><p><b>Impact:</b> Improved understanding of the hormonal etiology of prostate cancer is critical for prevention and therapeutic interventions. <i>Cancer Epidemiol Biomarkers Prev; 23(11); 2374–82. ©2014 AACR</i>.</p></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.